Oishi Tetsuro

• Komatsu H, Oishi T, Sato S, Osaku D, Sawada M, Kudoh A, Nonaka M, Sato S, Shimada M, Itamochi H, et al. Evaluating Chemotherapy-induced Nausea and Vomiting and Food Intake in Patients With Gynecologic Cancer. Anticancer Res. 2019. 39. 8. 4555-4560
• Sawada M, Oishi T, Komatsu H, Sato S, Chikumi J, Nonaka M, Kudoh A, Osaku D, Harada T. Serum vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 as prognostic biomarkers for uterine cervical cancer. Int J Clin Oncol. 2019
• Komatsu H, Oishi T, Osaku D, Sawada M, Kudoh A, Nonaka M, Chikumi J, Sato S, Harada T. Significance of High-Risk Human Papillomavirus Testing for Atypical Glandular Cells on Cervical Cytology. Acta Cytol. 2018. 10. 5-6. 1-6
• Hiroaki Komatsu, Tetsuro Oishi, Hiroaki Itamochi, Muneaki Shimada, Shinya Sato, Jun Chikumi, Seiya Sato, Michiko Nonaka, Mayumi Sawada, Makoto Wakahara, et al. Serum Vascular Endothelial Growth Factor-A as a Prognostic Biomarker for Epithelial Ovarian Cancer. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2017. 27. 7. 1325-1332
• Itamochi H, Oishi T, Oumi N, Takeuchi S, Yoshihara K, Mikami M, Yaegashi N, Terao Y, Takehara K, Ushijima K, et al. Whole-genome sequencing revealed novel prognostic biomarkers and promising targets for therapy of ovarian clear cell carcinoma. Br J Cancer. 2017. 117. 5. 717-724

ｍore...

• Seiya Sato, Hiroaki Itamochi, Junzo Kigawa, Tetsuro Oishi, Muneaki Shimada, Shinya Sato, Jun Naniwa, Kazunori Uegaki, Michiko Nonaka, Naoki Terakawa. Combination chemotherapy of oxaliplatin and 5-fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: A potential treatment strategy. CANCER SCIENCE. 2009. 100. 3. 546-551
• R. Shimogai, J. Kigawa, H. Itamochi, T. Iba, Y. Kanamori, T. Oishi, M. Shimada, S. Sato, W. Kawaguchi, S. Sato, et al. Expression of hypoxia-inducible factor 1 alpha gene affects the outcome in patients with ovarian cancer. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2008. 18. 3. 499-505
• Wakae Kawaguchi, Hiroaki Itamochi, Junzo Kigawa, Yasunobu Kanamori, Tetsuro Oishi, Muneaki Shimada, Sinya Sato, Ruri Shimogai, Seiya Sato, Naoki Terakawa. Simultaneous inhibition of the mitogen-activated protein kinase kinase and phosphatidylinositol 3'-kinase pathways enhances sensitivity to paclitaxel in ovarian carcinoma. CANCER SCIENCE. 2007. 98. 12. 2002-2008
• T. Oishi, H. Itamochi, J. Kigawa, Y. Kanamori, M. Shimada, M. Takahashi, R. Shimogai, W. Kawaguchi, S. Sato, N. Terakawa. Galectin-3 may contribute to Cisplatin resistance in clear cell carcinoma of the ovary. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2007. 17. 5. 1040-1046
• Hiroaki Itamochi, Junzo Kigawa, Yasunobu Kanamori, Tetsuro Oishi, Chandra Bartholomeusz, Rita Nahta, Francisco J. Esteva, Nour Sneige, Naoki Terakawa, Naoto T. Ueno. Adenovirus type 5 E1A gene therapy for ovarian clear cell carcinoma: a potential treatment strategy. MOLECULAR CANCER THERAPEUTICS. 2007. 6. 1. 227-235

ｍore...

• 2010/04 - Tottori University Hospital
• 2010 - - Lecturer,
• 2007/04 - Tottori University Faculty of Medicine
• 2007 - - Assistant professor, Faculty of Medicine,
• 2002/01 - Tottori University Faculty of Medicine
2002 - - 6 Research Associate, Faculty of Medicine,
Tottori University Hospital
Tottori University

American Association for Cancer Research ,  日本臨床細胞学会 ,  婦人科悪性腫瘍化学療法研究機構 ,  日本婦人科腫瘍学会 ,  日本癌治療学会 ,  日本癌学会 ,  日本産科婦人科学会 ,  JSCC ,  AACR ,  JGOG ,  JSGO ,  JSCO ,  JCA ,  JSOG ,  THE JAPAN SOCIETY OF HUMAN GENETICS ,  JAPANESE SOCIETY OF GYNECOLOGICAL CANCER SCREENING